BMJ Best Practice

参考文献

参考文章

1.  Sterry W; European Dermatology Forum Guideline Committee. Guidelines: the management of basal cell carcinoma. Eur J Dermatol. 2006;16:467-475.

2.  Lear W, Dahlke E, Murray CA. Basal cell carcinoma: review of epidemiology, pathogenesis, and associated risk factors. J Cutan Med Surg. 2007;11:19-30.

3.  Raasch BA, Buettner PG, Garbe C. Basal cell carcinoma: histological classification and body-site distribution. Br J Dermatol. 2006;155:401-407.

4.  Yu HS, Liao WT, Chai CY. Arsenic carcinogenesis in the skin. J Biomed Sci. 2006;13:657-666.

5.  Bath-Hextall FJ, Perkins W, Bong J, et al. Interventions for basal cell carcinoma of the skin. Cochrane Database Syst Rev. 2007;(1):CD003412.

6.  Miller SJ, Alam M, Andersen J, et al; National Comprehensive Cancer Network. Basal cell and squamous cell skin cancers. J Natl Compr Canc Netw. 2007;5:506-529.

7.  Rundel RD. Promotional effects of ultraviolet radiation on human basal and squamous cell carcinoma. Photochem Photobiol. 1983;38:569-575.

8.  Yarbro JW, Page DL, Fielding LP, et al. American Joint Committee on Cancer prognostic factors consensus conference. Cancer. 1999;86:2436-2446.

9.  Motley RJ, Preston PW, Lawrence CM; British Association of Dermatologists. Multi-professional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. 2009. http://www.bad.org.uk (last accessed 7 August 2017).

10.  Lin JS, Eder M, Weinmann S. Behavioral counseling to prevent skin cancer: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2011;154:190-201.

11.  Green A, Williams G, Neale R, et al. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinoma of the skin: a randomised controlled trial. Lancet. 1999;345:723-729.

12.  Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use. N Engl J Med. 1993;329:1147-1151.

13.  Darlington S, Williams G, Neale R, et al. A randomized controlled trial to assess sunscreen application and beta carotene supplementation in the prevention of solar keratoses. Arch Dermatol. 2003;139:451-455.

14.  Farmer KC, Naylor MF. Sun exposure, sunscreens, and skin cancer prevention: a year-round concern. Ann Pharmacother. 1996;30:662-673.

15.  Hofbauer GF, Anliker M, Arnold A, et al. Swiss clinical practice guidelines for skin cancer in organ transplant recipients. Swiss Med Wkly. 2009;139:407-415.

16.  Radhi JM. Malignant melanoma arising from nevi, p53, p16, and Bcl-2: expression in benign nevus versus malignant components. J Cutan Med Surg. 1999;3:293-297.

17.  Nestle FO, Kerl H. Melanoma. In: Bolognia JL, Jorizzo Jl, Rapini RP, eds. Dermatology, 2nd ed. Philadelphia, PA: Elsevier; 2007:1745-1769.

18.  Gilchrest BA, Eller MS, Geller AC, et al. The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med. 1999;340:1341-1348.

19.  Ting W, Schultz K, Cac NN, et al. Tanning bed exposure increases the risk of malignant melanoma. Int J Dermatol. 2007;46:1253-1257.

20.  Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 1994;266:1865-1869.

21.  Portsmouth S, Stebbing J, Gill J, et al. A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma. AIDS. 2003;17:F17-F22.

22.  Marks R, Rennie G, Selwood TS. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet. 1988;1:795-797.

23.  Glogau RG. The risk of progression to invasive disease. J Am Acad Dermatol. 2000;42:23-24.

24.  Werner RN, Stockfleth E, Connolly SM, et al; International League of Dermatological Societies, European Dermatology Forum. Evidence- and consensus-based (S3) guidelines for the treatment of actinic keratosis - short version. J Eur Acad Dermatol Venereol. 2015;29:2069-2079.

25.  Han A, Maibach HI. Management of acute sunburn. Am J Clin Dermatol. 2004;5:39-47.

使用此内容应接受我们的免责声明。